Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Good news for acute myeloid leukaemia patients from the stroll niche?

Ciciarello M, Curti A.

Br J Haematol. 2020 Jan 21. doi: 10.1111/bjh.16395. [Epub ahead of print] No abstract available.

PMID:
31960415
2.

The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma.

Tolomelli G, Mancuso K, Tacchetti P, Patriarca F, Galli M, Pantani L, Zannetti B, Motta MR, Rizzi S, Dan E, Sinigaglia B, Giudice V, Olmo A, Arpinati M, Chirumbolo G, Fanin R, Lewis RE, Paris L, Bonifazi F, Cavo M, Curti A, Lemoli RM.

Bone Marrow Transplant. 2019 Nov 25. doi: 10.1038/s41409-019-0756-1. [Epub ahead of print]

PMID:
31768009
3.

CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML.

Salomé B, Gomez-Cadena A, Loyon R, Suffiotti M, Salvestrini V, Wyss T, Vanoni G, Ruan DF, Rossi M, Tozzo A, Tentorio P, Bruni E, Riether C, Jacobsen EM, Jandus P, Conrad C, Hoenig M, Schulz A, Michaud K, Della Porta MG, Salvatore S, Ho PC, Gfeller D, Ochsenbein A, Mavilio D, Curti A, Marcenaro E, Steinle A, Horowitz A, Romero P, Trabanelli S, Jandus C.

Blood Adv. 2019 Nov 26;3(22):3674-3687. doi: 10.1182/bloodadvances.2018030478.

4.

The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia.

Ciciarello M, Corradi G, Loscocco F, Visani G, Monaco F, Cavo M, Curti A, Isidori A.

Front Oncol. 2019 Oct 25;9:1135. doi: 10.3389/fonc.2019.01135. eCollection 2019. Review.

5.

Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia.

Ocadlikova D, Lecciso M, Isidori A, Loscocco F, Visani G, Amadori S, Cavo M, Curti A.

Front Oncol. 2019 Oct 9;9:1004. doi: 10.3389/fonc.2019.01004. eCollection 2019. Review.

6.

BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia.

Loscocco F, Visani G, Galimberti S, Curti A, Isidori A.

Front Oncol. 2019 Sep 24;9:939. doi: 10.3389/fonc.2019.00939. eCollection 2019. Review.

7.

Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function.

Ulbar F, Montemurro T, Jofra T, Capri M, Comai G, Bertuzzo V, Lavazza C, Mandelli A, Viganò M, Budelli S, Bacalini MG, Pirazzini C, Garagnani P, Giudice V, Sollazzo D, Curti A, Arpinati M, La Manna G, Cescon M, Pinna AD, Franceschi C, Battaglia M, Giordano R, Catani L, Lemoli RM.

J Transl Med. 2019 Aug 5;17(1):250. doi: 10.1186/s12967-019-2004-2.

8.

Acute Myeloid Leukemia Mutations: Therapeutic Implications.

Papayannidis C, Sartor C, Marconi G, Fontana MC, Nanni J, Cristiano G, Parisi S, Paolini S, Curti A.

Int J Mol Sci. 2019 Jun 3;20(11). pii: E2721. doi: 10.3390/ijms20112721. Review.

9.

Genomic profiling and predicting treatment response in acute myeloid leukemia.

Isidori A, Loscocco F, Curti A, Amadori S, Visani G.

Pharmacogenomics. 2019 May;20(7):467-470. doi: 10.2217/pgs-2018-0202. No abstract available.

10.

The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment.

De Marchi E, Orioli E, Pegoraro A, Sangaletti S, Portararo P, Curti A, Colombo MP, Di Virgilio F, Adinolfi E.

Oncogene. 2019 May;38(19):3636-3650. doi: 10.1038/s41388-019-0684-y. Epub 2019 Jan 17.

11.

Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia.

Bertamini L, Nanni J, Marconi G, Abbenante M, Robustelli V, Bacci F, Matti A, Paolini S, Sartor C, Monaco SL, Fontana MC, De Polo S, Cavo M, Curti A, Martinelli G, Papayannidis C.

BMC Cancer. 2018 Nov 15;18(1):1117. doi: 10.1186/s12885-018-5026-x.

12.

Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.

Corradi G, Baldazzi C, Očadlíková D, Marconi G, Parisi S, Testoni N, Finelli C, Cavo M, Curti A, Ciciarello M.

Stem Cell Res Ther. 2018 Oct 25;9(1):271. doi: 10.1186/s13287-018-1013-z.

13.

Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes.

Bonifazi F, Olivieri J, Sessa M, Dan E, Sinigaglia B, Rizzi S, Motta MR, Bontadini A, Ulbar F, Giudice V, Papayannidis C, Curti A, Chiereghin A, Lazzarotto T, Cavo M, Arpinati M.

Biol Blood Marrow Transplant. 2018 Dec;24(12):2450-2458. doi: 10.1016/j.bbmt.2018.07.011. Epub 2018 Jul 17.

14.

Immunosenescence and Immunotherapy in Elderly Acute Myeloid Leukemia Patients: Time for a Biology-Driven Approach.

Isidori A, Loscocco F, Ciciarello M, Corradi G, Lecciso M, Ocadlikova D, Parisi S, Salvestrini V, Amadori S, Visani G, Curti A.

Cancers (Basel). 2018 Jun 22;10(7). pii: E211. doi: 10.3390/cancers10070211. Review.

15.

Work disability in Argentinian patients with systemic lupus erythematosus is prevalent and it is due to ethnic, socioeconomic and disease-related factors.

Pisoni CN, Muñoz SA, Tamborenea MN, García M, Curti A, Cappuccio A, Rillo O, Imamura PM, Schneeberger E, Ballent M, Cousseau ML, Velasco Zamora J, Saurit V, Toloza S, Danielsen MC, Bellomio VI, Graf C, Paira S, Cavallasca J, Pons Estel B, Moreno JLC, Díaz M, Alba P, Verando M, Tate G, Mysler E, Sarano J, Civit EE, Risueño F, Álvarez Sepúlveda P, Larroude MS, Méndez MF, Conforti A, Sohn D.

Int J Rheum Dis. 2018 Nov;21(11):2019-2027. doi: 10.1111/1756-185X.13269. Epub 2018 Apr 2.

PMID:
29611343
16.

Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health.

Mostacci B, Bisulli F, Poluzzi E, Cocchi G, Piccinni C, Curti A, Simonazzi G, Astolfi G, Rizzo N, Zenesini C, D'Alessandro R, Tinuper P; ESPEA Study Group.

J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):983-988. doi: 10.1136/jnnp-2017-317833. Epub 2018 Mar 16.

17.

Flow cytometry analysis of T-cell subsets in cerebrospinal fluid of narcolepsy type 1 patients with long-lasting disease.

Moresco M, Lecciso M, Ocadlikova D, Filardi M, Melzi S, Kornum BR, Antelmi E, Pizza F, Mignot E, Curti A, Plazzi G.

Sleep Med. 2018 Apr;44:53-60. doi: 10.1016/j.sleep.2017.11.1150. Epub 2018 Jan 3.

PMID:
29530370
18.

First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker analysis from an Italian oncology group for clinical research (GOIRC) phase II study.

Tomasello G, Valeri N, Ghidini M, Smyth EC, Liguigli W, Toppo L, Mattioli R, Curti A, Hahne JC, Negri FM, Panni S, Ratti M, Lazzarelli S, Gerevini F, Colombi C, Panni A, Rovatti M, Treccani L, Martinotti M, Passalacqua R.

Oncotarget. 2017 Dec 4;8(67):111795-111806. doi: 10.18632/oncotarget.22909. eCollection 2017 Dec 19.

19.

ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells.

Lecciso M, Ocadlikova D, Sangaletti S, Trabanelli S, De Marchi E, Orioli E, Pegoraro A, Portararo P, Jandus C, Bontadini A, Redavid A, Salvestrini V, Romero P, Colombo MP, Di Virgilio F, Cavo M, Adinolfi E, Curti A.

Front Immunol. 2017 Dec 22;8:1918. doi: 10.3389/fimmu.2017.01918. eCollection 2017.

20.

The More, The Better: "Do the Right Thing" For Natural Killer Immunotherapy in Acute Myeloid Leukemia.

Parisi S, Lecciso M, Ocadlikova D, Salvestrini V, Ciciarello M, Forte D, Corradi G, Cavo M, Curti A.

Front Immunol. 2017 Oct 19;8:1330. doi: 10.3389/fimmu.2017.01330. eCollection 2017. Review.

21.

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.

Trabanelli S, Chevalier MF, Martinez-Usatorre A, Gomez-Cadena A, Salomé B, Lecciso M, Salvestrini V, Verdeil G, Racle J, Papayannidis C, Morita H, Pizzitola I, Grandclément C, Bohner P, Bruni E, Girotra M, Pallavi R, Falvo P, Leibundgut EO, Baerlocher GM, Carlo-Stella C, Taurino D, Santoro A, Spinelli O, Rambaldi A, Giarin E, Basso G, Tresoldi C, Ciceri F, Gfeller D, Akdis CA, Mazzarella L, Minucci S, Pelicci PG, Marcenaro E, McKenzie ANJ, Vanhecke D, Coukos G, Mavilio D, Curti A, Derré L, Jandus C.

Nat Commun. 2017 Sep 19;8(1):593. doi: 10.1038/s41467-017-00678-2.

22.

Molecular and functional characterization of CD133+ stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells.

Catani L, Sollazzo D, Bianchi E, Ciciarello M, Antoniani C, Foscoli L, Caraceni P, Giannone FA, Baldassarre M, Giordano R, Montemurro T, Montelatici E, D'Errico A, Andreone P, Giudice V, Curti A, Manfredini R, Lemoli RM.

Cytotherapy. 2017 Dec;19(12):1447-1461. doi: 10.1016/j.jcyt.2017.08.001. Epub 2017 Sep 14.

PMID:
28917627
23.

Perinatal Outcomes of Non-Primary Maternal Cytomegalovirus Infection: A 15-Year Experience.

Simonazzi G, Curti A, Cervi F, Gabrielli L, Contoli M, Capretti MG, Rizzo N, Guerra B, Farina A, Lazzarotto T.

Fetal Diagn Ther. 2018;43(2):138-142. doi: 10.1159/000477168. Epub 2017 Jul 12.

PMID:
28697499
24.

Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells.

Salati S, Salvestrini V, Carretta C, Genovese E, Rontauroli S, Zini R, Rossi C, Ruberti S, Bianchi E, Barbieri G, Curti A, Castagnetti F, Gugliotta G, Rosti G, Bergamaschi M, Tafuri A, Tagliafico E, Lemoli R, Manfredini R.

Oncotarget. 2017 Jul 25;8(30):49451-49469. doi: 10.18632/oncotarget.17706.

25.

Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells.

Salvestrini V, Orecchioni S, Talarico G, Reggiani F, Mazzetti C, Bertolini F, Orioli E, Adinolfi E, Di Virgilio F, Pezzi A, Cavo M, Lemoli RM, Curti A.

Oncotarget. 2017 Jan 24;8(4):5895-5908. doi: 10.18632/oncotarget.13927.

26.

The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.

Forte D, Salvestrini V, Corradi G, Rossi L, Catani L, Lemoli RM, Cavo M, Curti A.

Oncotarget. 2017 Jan 10;8(2):2261-2274. doi: 10.18632/oncotarget.13664.

27.

Novel strategies of adoptive immunotherapy: How natural killer cells may change the treatment of elderly patients with acute myeloblastic leukemia.

Lemoli RM, Parisi S, Curti A.

Exp Hematol. 2017 Jan;45:10-16. doi: 10.1016/j.exphem.2016.10.007. Epub 2016 Nov 5. Review.

PMID:
27826123
28.

Safety and efficacy of dose-dense chemotherapy with TCF regimen in elderly patients with locally advanced or metastatic gastric cancer.

Liguigli W, Tomasello G, Toppo L, Poli R, Lazzarelli S, Negri F, Perrucci B, Curti A, Brighenti M, Donati G, Nazzari M, Martinotti M, Vismarra M, Rovatti M, Passalacqua R.

Tumori. 2017 Jan 21;103(1):93-100. doi: 10.5301/tj.5000556. Epub 2016 Aug 23.

PMID:
27647222
29.

Simulating the selfing and migration of Luehea divaricata populations in the Pampa biome to investigate the conservation potential of their genetic resources.

Serrote CM, Reiniger LR, Stefenon VM, Curti AR, Costa LS, Paim AF.

Genet Mol Res. 2016 Aug 29;15(3). doi: 10.4238/gmr.15038410.

PMID:
27706630
30.

Therapeutic Efficacy and Cost Effectiveness of High Cut-Off Dialyzers Compared to Conventional Dialysis in Patients with Cast Nephropathy.

Curti A, Schwarz A, Trachsler J, Tomonaga Y, Ambühl PM.

PLoS One. 2016 Jul 28;11(7):e0159942. doi: 10.1371/journal.pone.0159942. eCollection 2016.

31.

Maternal plasma mRNA species in fetal heart defects: a potential for molecular screening.

Curti A, Lapucci C, Berto S, Prandstraller D, Perolo A, Rizzo N, Farina A.

Prenat Diagn. 2016 Aug;36(8):738-43. doi: 10.1002/pd.4853. Epub 2016 Jul 4.

PMID:
27257136
32.

Advances in clinical NK cell studies: Donor selection, manufacturing and quality control.

Koehl U, Kalberer C, Spanholtz J, Lee DA, Miller JS, Cooley S, Lowdell M, Uharek L, Klingemann H, Curti A, Leung W, Alici E.

Oncoimmunology. 2015 Nov 11;5(4):e1115178. eCollection 2016 Apr.

33.

Performance of Circulating Placental Growth Factor as A Screening Marker for Diagnosis of Ovarian Endometriosis: A Pilot Study.

Zucchini C, De Sanctis P, Facchini C, Di Donato N, Montanari G, Bertoldo V, Farina A, Curti A, Seracchioli R.

Int J Fertil Steril. 2016 Jan-Mar;9(4):483-9. Epub 2015 Dec 23.

34.

Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients.

Curti A, Ruggeri L, Parisi S, Bontadini A, Dan E, Motta MR, Rizzi S, Trabanelli S, Ocadlikova D, Lecciso M, Giudice V, Fruet F, Urbani E, Papayannidis C, Martinelli G, Bandini G, Bonifazi F, Lewis RE, Cavo M, Velardi A, Lemoli RM.

Clin Cancer Res. 2016 Apr 15;22(8):1914-21. doi: 10.1158/1078-0432.CCR-15-1604. Epub 2016 Jan 19.

35.

Alloreactive Natural Killer Cells for the Treatment of Acute Myeloid Leukemia: From Stem Cell Transplantation to Adoptive Immunotherapy.

Ruggeri L, Parisi S, Urbani E, Curti A.

Front Immunol. 2015 Oct 15;6:479. doi: 10.3389/fimmu.2015.00479. eCollection 2015. Review.

36.

Prenatal ultrasonographic features of mature cystic teratoma in undescended testicle.

Youssef A, Salsi G, Curti A, Bellussi F, Elbarbary NA, Locatelli F, Lima M, Pilu G, Rizzo N.

Ultrasound Obstet Gynecol. 2016 Apr;47(4):527-9. doi: 10.1002/uog.15769. No abstract available.

37.

Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis.

Forte D, Ciciarello M, Valerii MC, De Fazio L, Cavazza E, Giordano R, Parazzi V, Lazzari L, Laureti S, Rizzello F, Cavo M, Curti A, Lemoli RM, Spisni E, Catani L.

Stem Cell Res Ther. 2015 Sep 9;6:170. doi: 10.1186/s13287-015-0166-2.

38.

The Human Mesenchymal Stromal Cell-Derived Osteocyte Capacity to Modulate Dendritic Cell Functions Is Strictly Dependent on the Culture System.

Trabanelli S, La Manna F, Romano M, Salvestrini V, Cavo M, Ciciarello M, Lemoli RM, Curti A.

J Immunol Res. 2015;2015:526195. doi: 10.1155/2015/526195. Epub 2015 Jul 12.

39.

The tissue inhibitor of metalloproteinases 1 increases the clonogenic efficiency of human hematopoietic progenitor cells through CD63/PI3K/Akt signaling.

Rossi L, Forte D, Migliardi G, Salvestrini V, Buzzi M, Ricciardi MR, Licchetta R, Tafuri A, Bicciato S, Cavo M, Catani L, Lemoli RM, Curti A.

Exp Hematol. 2015 Nov;43(11):974-985.e1. doi: 10.1016/j.exphem.2015.07.003. Epub 2015 Jul 23.

PMID:
26213230
40.

Cervical lacerations in planned versus labor cerclage removal: a systematic review.

Simonazzi G, Curti A, Bisulli M, Seravalli V, Saccone G, Berghella V.

Eur J Obstet Gynecol Reprod Biol. 2015 Oct;193:19-22. doi: 10.1016/j.ejogrb.2015.06.032. Epub 2015 Jul 9. Review.

PMID:
26209805
41.

PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response.

Trabanelli S, Lecciso M, Salvestrini V, Cavo M, Očadlíková D, Lemoli RM, Curti A.

J Immunol Res. 2015;2015:253191. doi: 10.1155/2015/253191. Epub 2015 Feb 26.

42.

CD127+ innate lymphoid cells are dysregulated in treatment naïve acute myeloid leukemia patients at diagnosis.

Trabanelli S, Curti A, Lecciso M, Salomé B, Riether C, Ochsenbein A, Romero P, Jandus C.

Haematologica. 2015 Jul;100(7):e257-60. doi: 10.3324/haematol.2014.119602. Epub 2015 Feb 20. No abstract available.

43.

Serum and Urinary Neutrophil Gelatinase-associated Lipocalin Monitoring in Normal Pregnancy Versus Pregnancies Complicated by Pre-eclampsia.

Simonazzi G, Capelli I, Curti A, Comai G, Rizzo N, La Manna G.

In Vivo. 2015 Jan-Feb;29(1):117-21.

PMID:
25600539
44.

CD103 marks a subset of human CD34+-derived langerin+ dendritic cells that induce T-regulatory cells via indoleamine 2,3-dioxygenase-1.

Očadlíková D, Trabanelli S, Salvestrini V, Ciciarello M, Evangelisti C, Lecciso M, Sabattini E, Righi S, Piccioli M, Pileri SA, Lemoli RM, Curti A.

Exp Hematol. 2015 Apr;43(4):268-76.e5. doi: 10.1016/j.exphem.2014.12.007. Epub 2015 Jan 10.

PMID:
25584868
45.

Fetal cerebellar damage in fetuses with severe anemia undergoing intrauterine transfusions.

Simonazzi G, Bernabini D, Curti A, Bisulli M, Pilu G, Brill CB, Rizzo N, Berghella V.

J Matern Fetal Neonatal Med. 2016;29(3):389-92. doi: 10.3109/14767058.2014.1001973. Epub 2015 Jan 12.

PMID:
25579117
46.

Fetal cardiac defects and third-trimester maternal serum placental growth factor.

Curti A, Zucchini C, De Maggio I, Ismail YS, Morano D, Falcone V, Meriggiola MC, Farina A.

Ultrasound Obstet Gynecol. 2015 Jun;45(6):751-2. doi: 10.1002/uog.14748. Epub 2015 May 11. No abstract available.

47.

The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment.

Isidori A, Salvestrini V, Ciciarello M, Loscocco F, Visani G, Parisi S, Lecciso M, Ocadlikova D, Rossi L, Gabucci E, Clissa C, Curti A.

Expert Rev Hematol. 2014 Dec;7(6):807-18. doi: 10.1586/17474086.2014.958464. Epub 2014 Sep 16. Review.

PMID:
25227702
48.

Circulating mRNA for the PLAC1 gene as a second trimester marker (14-18 weeks' gestation) in the screening for late preeclampsia.

Zanello M, Sekizawa A, Purwosunu Y, Curti A, Farina A.

Fetal Diagn Ther. 2014;36(3):196-201. doi: 10.1159/000360854. Epub 2014 Aug 15.

49.

Congenital cytomegalovirus infection and small for gestational age infants.

Simonazzi G, Curti A, Murano P, Cervi F, Contoli M, Lazzarotto T, Capretti MG, Rizzo N, Guerra B.

Prenat Diagn. 2014 Aug;34(8):765-9. doi: 10.1002/pd.4362. Epub 2014 Apr 15.

PMID:
24665022
50.

The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells.

Trabanelli S, Očadlíková D, Ciciarello M, Salvestrini V, Lecciso M, Jandus C, Metz R, Evangelisti C, Laury-Kleintop L, Romero P, Prendergast GC, Curti A, Lemoli RM.

J Immunol. 2014 Feb 1;192(3):1231-40. doi: 10.4049/jimmunol.1300720. Epub 2014 Jan 3.

Supplemental Content

Support Center